Elevated levels of PF4+ pEVs have been reported in sepsis (Sartori et al., 2020), and there is evidence that HMGB1+ pEVs are significantly elevated in COVID-19 (Maugeri et al., 2022). The gene discussed is PF4; the disease is COVID-19.